Drug products: Cortimyk, Daktacort®, Fenuril®-Hydrokortison, Ficortril®, Fucidin®-Hydrocortison, Fucidin-Hydrocortison, Fusidinsyra/Hydrokortison 2care4, Hydrokortison Apofri, Hydrokortison Evolan, Hydrokortison PharmSwed, Hydrokortison-svavel i Essex kräm APL, Locoid, Locoid Crelo, Locoid Lipid, Locoid®, Mildison Lipid, Softacort, Terracortril med polymyxin B, Terracortril med Polymyxin B, Terra-Cortril med polymyxin B, Terracortril®, Terracortril® med Polymyxin B, Uniderm®, Xerclear, Zoviduo
ATC code: D01AC20, D06BB53, D07AA02, D07AB02, D07CA01, D07XA01, S01BA02, S03CA04
Controlled studies on differences between men and women regarding efficacy, safety and pharmacokinetics of topical hydrocortisone are lacking.
The present evidence concerning differences between men and women is limited and do not motivate differentiation in dosing or treatment.
No studies with a clinical relevant sex analysis regarding the pharmacokinetics or dosing of topical hydrocortisone have been found.
No studies with a clinical relevant sex analysis regarding the effects of topical hydrocortisone have been found.
No studies with a clinical relevant sex analysis regarding the adverse effects of topical hydrocortisone have been found.
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Date of litterature search: 2015-11-27
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson